Health Canada
- Status: approved
🇨🇦 Cabotegravir Injection [Apretude] in Canada
Cabotegravir Injection [Apretude] (Cabotegravir Injection [Apretude]) regulatory status in Canada.
Marketing authorisation
Cabotegravir Injection [Apretude] in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Cabotegravir Injection [Apretude] approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Cabotegravir Injection [Apretude] in Canada?
University of Witwatersrand, South Africa is the originator. The local marketing authorisation holder may differ — check the official source linked above.